WallStSmart
FBIO

Fortress Biotech Inc Pref Series A

NASDAQ: FBIOP · HEALTHCARE · BIOTECHNOLOGY

$14.39
-0.21% today

Updated 2026-04-30

Market cap
$76.49M
P/E ratio
P/S ratio
1.21x
EPS (TTM)
$-0.86
Dividend yield
52W range
$6 – $15
Volume
0.0M

Fortress Biotech Inc Pref Series A (FBIOP) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+143.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+2.5%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+2.5%
2025-11-14
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-11-14$0.11$6.53$6.69+2.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$0.00$0.11$17.63M
2025-06-30$0.00$0.45$16.41M
2025-03-31$0.00$-0.48$13.14M
2024-12-31$0.00$-0.37$15.12M
2021-06-30$0.00$-0.26
2021-03-31$0.00$-0.04
2020-12-31$0.00$-0.11
2020-09-30$0.00$-0.07
2020-06-30$-0.27$-0.19+29.6%
2020-03-31$-0.23$-0.19+17.4%
2019-12-31$-0.31$-0.27+12.9%
2019-09-30$-0.30$-0.22+26.7%

Frequently asked questions

Has Fortress Biotech Inc Pref Series A beaten earnings estimates?
Fortress Biotech Inc Pref Series A has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports.
How does FBIOP stock react to earnings?
FBIOP stock has moved an average of +2.5% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.